Global Chondroplasty Market, By Type (Radiofrequency Ablation Chondroplasty, Abrasion Chondroplasty, Atellar Chondroplasty, Meniscal Repair, Tissue Removal, and Others), Anatomy (Knee, Shoulder, Hip and Others), Equipment (Shavers, Radiofrequency Devices, Arthroscope, and Others), End Use (Hospitals, Orthopedic Clinics, Academic Research, and Others) - Industry Trends and Forecast to 2030.
Chondroplasty Market Analysis and Size:
The increasing prevalence of joint disorders is one of the major factors driving the market's growth. The advancements in medical technology and increasing healthcare infrastructure expenditure accelerate the chondroplasty market growth.
Data Bridge Market Research analyses that the global chondroplasty market which was USD 12,545,2 million in 2022, would rocket up to USD 16,263.4 million by 2030 and is expected to undergo a CAGR of 8.2 % during the forecast period. This indicates that the radiofrequency ablation chondroplasty segment dominates the type segment of the chondroplasty market. Technological advancements have led to the development of advancements in drug products for various use.
In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Chondroplasty Market Scope and Segmentation
|
Report Metric |
Details |
|
Forecast Period |
2023 to 2030 |
|
Base Year |
2022 |
|
Historic Years |
2021 (Customizable 2015-2020) |
|
Quantitative Units |
Revenue in USD Million, Volumes in Units, Pricing in USD |
|
Segments Covered |
By Type (Radiofrequency Ablation Chondroplasty, Abrasion Chondroplasty, Atellar Chondroplasty, Meniscal Repair, Tissue Removal, and Others), Anatomy (Knee, Shoulder, Hip and Others), Equipment (Shavers, Radiofrequency Devices, Arthroscope, and Others), End Use (Hospitals, Orthopedic Clinics, Academic Research, and Others) |
|
Countries Covered |
U.S., Canada, Mexico, Brazil, Argentina, Peru, rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, rest of Middle East and Africa |
|
Market Players Covered |
B. Braun Melsungen AG (U.S.), Stryker (U.S.), Zimmer Biomet (U.S.), Smith & Nephew plc (U.S.), Nebula Inc. (U.S.), GPC Medical, Osiris. (U.S.), NuOrtho Surgical, Inc. (U.S.), Sklar Surgical Instruments. (U.S.), Isto Biologics, Medical Devices Business Services, Inc. (U.S.), Ocugen, Inc. (U.S.), MEDIPOST (South Korea), Takeda Pharmaceutical Company Limited. (Japan), Teva Pharmaceutical Company Limited. (U.S.), Vericel Corporation. (U.S.), Promega Corporation. (U.S.), Sigma-Aldrich Co. (U.S.), Thermo Fisher Scientific Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), F. Hoffmann-La Roche Ltd. (U.S.), and QIAGEN (U.S.) among others |
|
Market Opportunities |
|
Market Definition
Chondroplasty is a surgical procedure performed to repair or reshape damaged cartilage in joints, particularly in the knee. It is commonly used to treat osteoarthritis, cartilage injuries, and other joint-related disorders. These may include arthroscopic instruments, shavers, drills, abrasion systems, chondroscopes, and other specialized tools. Additionally, biologics such as growth factors, stem cells, and tissue grafts may also be utilized in chondroplasty procedures.
Global Chondroplasty Market Dynamics
Drivers
- Increasing prevalence of joint-related disorders:
The rising incidence of joint-related disorders such as osteoarthritis, chondromalacia, and meniscus tears is a significant driver for the chondroplasty market. These conditions often require surgical interventions, including chondroplasty, to repair or remove damaged cartilage.
- Growing geriatric population:
The aging population is prone to developing joint-related issues due to cartilage's natural wear and tear over time. The increasing number of elderly individuals globally drives the demand for chondroplasty procedures to address joint pain and improve mobility.
- Technological advancements in surgical techniques
Advances in surgical techniques, including minimally invasive procedures and arthroscopic chondroplasty, have made the treatment more accessible, less invasive, and associated with faster recovery times. These advancements have increased patient acceptance and propelled market growth.
Opportunities
- Growing demand for regenerative medicine:
The field of regenerative medicine has gained significant attention in recent years, focusing on repairing and regenerating damaged tissues, including cartilage. Chondroplasty techniques that promote cartilage regeneration, such as microfracture and autologous chondrocyte implantation (ACI), are in high demand, driving market growth.
- Favorable reimbursement policies:
Favorable reimbursement policies and insurance coverage for chondroplasty procedures in several countries encourage patients to seek treatment and positively impact market growth. Reimbursement support reduces the financial burden on patients and increases the accessibility of chondroplasty procedures.
Challenges/ Restraints
- Limited Awareness and Adoption:
Chondroplasty is a surgical procedure to repair damaged cartilage in joints, such as the knee. However, there may be a lack of awareness among patients and healthcare professionals about the benefits and availability of chondroplasty. This limited awareness and adoption could restrain the market growth.
- Technological Limitations
The success of chondroplasty relies on the availability of advanced surgical techniques and equipment. Technological limitations, such as the lack of innovative tools or imaging modalities, could impact the effectiveness and outcomes of chondroplasty procedures. Advancements in technology are necessary to enhance surgical precision and optimize patient outcomes.
This global chondroplasty market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the Global Chondroplasty Market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Recent Development
- In May 2023, Teva Pharmaceutical Industries Ltd. announced a new strategic framework with four main pillars to position the company for a new era of growth. This strategy aims to bolster the company’s strong commercial portfolio with AUSTEDO, AJOVY, UZEDYTM and biosimilars, amplify its innovative pipeline, sustain its generics powerhouse and focus the business
- In November 2022, the wholly-owned subsidiary of Sun Pharmaceutical Industries Limited (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715, “Sun Pharma” and includes its subsidiaries and associate companies) and Sun Pharma Advanced Research Company Ltd.
Global Chondroplasty Market Scope
The global chondroplasty market is segmented on the basis type, anatomy, equipment, and end-use. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
By Type
- Radiofrequency Ablation Chondroplast
- Abrasion Chondroplasty
- Atellar Chondroplasty
- Meniscal Repair
- Tissue Removal
- Others
By Anatomy
- Knee
- Shoulder
- Hip
- Others
By Equipment
- Shavers
- Radiofrequency Devices,
- Arthroscope and Others
By End Use
- Hospitals
- Orthopedic Clinics
- Academic Research
- Others
Global Chondroplasty Market Regional Analysis/Insights
The global chondroplasty market is analysed and market size insights and trends are the basis type, anatomy, equipment, and end-use as referenced above.
The countries covered in the global chondroplasty market report are U.S., Canada, Mexico, Brazil, Argentina, Peru, rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, rest of Middle East and Africa.
North America is expected to dominate the chondroplasty market due to the presence of major key players, high disposable income, high healthcare expenditure, and a well-developed healthcare sector in this region.
Asia-Pacific is expected to grow during the forecast period of 2023-2030 due to the increasing research and development activities, rising investment in the healthcare sector, and growing government support.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impact the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed Base and New Technology Penetration
The global chondroplasty market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for global chondroplasty market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the market. The data is available for historic period 2015-2020.
Competitive Landscape and Global Chondroplasty Market Share Analysis
The global chondroplasty market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to market.
Some of the major players operating in the global chondroplasty market are:
- B. Braun Melsungen AG (U.S.)
- Stryker (U.S.)
- Zimmer Biomet (U.S.)
- Smith & Nephew plc (U.S.)
- Nebula Inc. (U.S.)
- GPC Medical, Osiris. (U.S.)
- NuOrtho Surgical, Inc. (U.S.)
- Sklar Surgical Instruments. (U.S.)
- Isto Biologics (U.S.)
- Medical Devices Business Services, Inc. (U.S.)
- Ocugen, Inc. (U.S.)
- MEDIPOST (South Korea)
- Takeda Pharmaceutical Company Limited. (Japan)
- Teva Pharmaceutical Company Limited. (U.S.)
- Vericel Corporation. (U.S.)
- Promega Corporation. (U.S.)
- Sigma-Aldrich Co. (U.S.)
- Thermo Fisher Scientific Inc. (U.S.)
- Bio-Rad Laboratories, Inc. (U.S.)
- F. Hoffmann-La Roche Ltd. (U.S.)
- QIAGEN (U.S.)
SKU-
